Urology Catheters Market Report 2026

The urology catheters market size has grown strongly in recent years. It will grow from $3.75 billion in 2025 to $4.03 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing incidence of urinary incontinence, rising surgical procedures requiring catheterization, expansion of hospital-based urology care, growing aging population, wider availability of urology catheter products.

The urology catheters market size is expected to see strong growth in the next few years. It will grow to $5.33 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing adoption of infection-prevention catheters, rising demand for home healthcare solutions, growing focus on patient-centric catheter designs, expansion of minimally invasive urology treatments, increasing use of eco-friendly catheter materials. Major trends in the forecast period include increasing adoption of anti-bacterial catheter technologies, rising demand for silicone-based catheters, growing use of single-use disposable catheters, expansion of home care catheterization solutions, enhanced focus on patient comfort and safety.

The rising incidence of bladder cancer is expected to drive growth in the urology catheter market. Bladder cancer originates in the cells of the bladder, a hollow, muscular organ in the lower abdomen responsible for storing urine. The increase in bladder cancer cases is attributed to aging populations, greater exposure to carcinogens, pelvic radiation, and low water intake habits. Urology catheters are essential for bladder cancer patients to manage urinary flow and drainage, particularly following surgeries or treatments that affect normal bladder function. For example, in July 2024, Cancer Research UK, a UK-based charity, reported that the average number of new bladder cancer cases in the UK is projected to rise from approximately 9,800 annually in 2023-2025 to around 10,700 cases per year by 2038-2040. Consequently, the growing incidence of bladder cancer is fueling the expansion of the urology catheter market.

Key players in the urology catheter market are concentrating on developing advanced products, such as next-generation intermittent urinary catheter systems, to improve patient comfort, reduce infection risks, and promote greater independence in bladder management. These next-generation systems are single-use or closed-system devices designed with enhanced materials, surface coatings, and drainage structures to minimize urethral trauma, facilitate hygienic handling, and lower the risks of encrustation or urinary tract infection. For instance, in February 2023, Denmark-based medical device company Coloplast A/S launched its Luja Coude intermittent catheter, cleared under FDA 510(k) K230165. The device features a flexible tip with multiple micro-holes to improve drainage, a hydrophilic coating to reduce friction and insertion trauma, and an ergonomic design available in multiple French sizes (8-16 Fr) for adult males and females with urinary retention or voiding dysfunction.

In October 2023, Laborie Medical Technologies Inc., a US-based provider of diagnostic and therapeutic equipment, acquired Urotronic Inc. for $600 million. Through this acquisition, Laborie aims to enhance its interventional urology portfolio by integrating Urotronic’s innovative Optilume drug-coated balloon technology. Urotronic Inc., based in the U.S., specializes in developing advanced urological medical devices, including urology catheters.

Major companies operating in the urology catheters market are Cardinal Health Inc., Medtronic PLC, Becton Dickinson and Company, Boston Scientific Corporation, Medline Industries Inc., B. Braun Melsungen AG, Coloplast A/S, Teleflex Incorporated, Cook Medical, ConvaTec Group PLC, Hollister Incorporated, Amsino International Inc., Well Lead Medical Co.Ltd., Urocare Products Inc., Bactiguard AB, CURE MEDICAL LLC., Degania Silicone Ltd., CompactCath Inc., Go Medical Industries Pty Ltd., UROTECH GmbH, J and M Urinary Catheters LLC.

North America was the largest region in the urology catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urology catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urology catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the urology catheters market by increasing costs of imported silicone materials, medical-grade polymers, coatings, and precision manufacturing equipment. Healthcare providers in North America and Europe are most affected due to reliance on imported catheter components, while Asia-Pacific faces cost pressure on catheter production and exports. These tariffs are contributing to higher product prices and procurement challenges. However, they are also encouraging domestic production of catheters, localized material sourcing, and innovation in cost-efficient and sustainable catheter manufacturing.

The urology catheters market research report is one of a series of new reports that provides urology catheters market statistics, including urology catheters industry global market size, regional shares, competitors with a urology catheters market share, detailed urology catheters market segments, market trends and opportunities, and any further data you may need to thrive in the urology catheters industry. This urology catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Urology catheters are medical devices used to assist in the drainage, collection, and management of urine from the bladder, particularly when a patient cannot urinate naturally due to conditions such as urinary retention, incontinence, or post-surgical recovery. These catheters are inserted into the bladder either through the urethra or via a small abdominal incision, depending on the type and medical requirement. They are designed to provide comfort, minimize the risk of infections, and ensure effective urinary management in both clinical and home care settings.

The main types of urology catheter products include intermittent catheters, Foley catheters, external catheters, and others. Intermittent catheters are single-use devices intended for temporary bladder insertion to drain urine. They are made from materials such as latex and silicone and are used for conditions including urinary incontinence, benign prostatic hyperplasia, and post-surgical care. End users include hospitals, clinics, ambulatory surgical centers, and home care settings.

The urology catheters market consists of sales of foley catheters. closed system catheters, hydrophilic catheters and pediatric catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.